This report was first published by Endpoints News. To see the original version, click here
HHS Secretary Robert F. Kennedy Jr. defended the FDA and Commissioner Marty Makary during a House hearing on Thursday morning, saying that Makary is under a lot of pressure from the pharma industry.
Rep. Darin LaHood (R-IL) questioned Kennedy before the House Ways and Means Committee on Thursday regarding Makary’s “mismanagement and bungled drug reviews,” and saying that the FDA has “chilled investments in life-saving, innovative cures, and that China is rapidly becoming the recipient of those investment dollars.”
您已阅读17%（608字），剩余83%（2885字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。